Showing results (21-30 of 62) with videos related to
Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|July 12, 2018
Surface Immobilization of Redox-Labile Fluorescent Probes: Enabling Single-Cell Co-Profiling of Aerobic Glycolysis and Oncogenic Protein Signaling ActivitiesZhonghan Li, Hanjun Cheng, Shiqun Shao, et al.Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.Cancer Research Communications|October 10, 2022
Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastomaAlvaro G Alvarado, Kaleab Tessema, Sree Deepthi Muthukrishnan, et al.Cancer Research Communications|June 10, 2024
Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in GliomaThomas J Lai, Lu Sun, Kevin Li, et al.Neuro-Oncology|May 30, 2025
Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastomaFrancesco Sanvito, Asher Kim, Catalina Raymond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade GliomaBenjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.Neuroradiology|October 27, 2020
Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomasTalia C Oughourlian, Jingwen Yao, Akifumi Hagiwara, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2025
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safetyYan-Ruide Li, Yichen Zhu, Zhe Li, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 4, 2026
Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine ToolPauline Jeanjean, Abir Swaidan, Christopher Tse, et al.Scientific Reports|February 28, 2019
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistryArarat Chakhoyan, Jingwen Yao, Kevin Leu, et al.Pageof 7